Earnings History Data for Zealand Pharma A/S (ZEAL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Zealand Pharma A/S

Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. Zealand Pharma A/S is based in Copenhagen, Denmark.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-05-2022	PM	0:00 AM ET (May 12)	ZEAL	Zealand Pharma A/S	479.69	-0.63	-1.01	-0.94	Zealand Pharma GAAP EPS of -DKK5.16 misses by $4.18, revenue of DKK15.07M beats by DKK5.59M [5/12/2022 9:18 AM]	10.25	-0.83 (-7.49%)	0.0	0.0 (0.00%)	9.98 - 34.30	5,026	0	0
Zealand Pharma GAAP EPS of -DKK5.16 misses by $4.18, revenue of DKK15.07M beats by DKK5.59M [5/12/2022 9:18 AM] Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Development [May-12-22 09:00AM] Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [May-12-22 12:05PM]
10-03-2022	PM	9:00 AM ET (Mar 10)	ZEAL	Zealand Pharma A/S	552.73	-1.00	-1.07	-1.56		13.76	0.75 (5.76%)	14.32	1.26 (9.65%)	12.27 - 36.95	1,604	8,576	0
Zealand Pharma reports FY results [3/10/2022 9:05 AM] Zealand Pharma convenes its Annual General Meeting 2022 [Mar-10-22 09:01AM] Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022. [Mar-10-22 09:00AM]
12-05-2021	PM	0:00 AM ET (May 12)	ZEAL	Zealand Pharma A/S	1,410	-0.94	-1.09	-0.74		29.40	-0.82 (-2.71%)	0.0	0.0 (0.00%)	29.40 - 44.42	1,245	0	0
Zealand Pharma plans U.S. launch of Zegalogue injection in June [5/12/2021 9:27 AM] Zealand Pharma launches long-term incentive program for Zealands Executive Management and employees for 2021 [May-12-21 07:00AM] Zealand Pharma receives first FDA approval and prepares for launch of Zegalogue® (dasiglucagon) injection [May-12-21 09:00AM] Zealand Pharma A/S to Host Earnings Call [May-12-21 01:45PM]
11-03-2021	PM	9:00 AM ET (Mar 11)	ZEAL	Zealand Pharma A/S	1,330	-1.56	-0.98	-0.80	Zealand Pharma misses on revenue [3/11/2021 10:30 AM]	32.68	1.45 (4.64%)	32.00	0.77 (2.47%)	22.00 - 44.42	9,322	12,819	1,005
Zealand Pharma misses on revenue [3/11/2021 10:30 AM] Zealand Pharma: on Track for Potential First Product Launch and Establishing Commercial Operations in the United States [Mar-11-21 09:00AM] Zealand Pharma A/S to Host Earnings Call [Mar-11-21 01:45PM]
12-11-2020	PM	9:00 AM ET (Nov 12)	ZEAL	Zealand Pharma A/S	1,510	-0.90	-0.80	-0.51	Zealand Pharma reports Q3 results [11/12/2020 9:07 AM]	36.85	-1.20 (-3.15%)	0.0	0.0 (0.00%)	22.00 - 44.60	3,999	4,219	0

14-05-2020	PM	0:00 AM ET (May 14)	ZEAL	Zealand Pharma A/S	1,360	-0.74	-0.63	-0.63		38.13	2.12 (5.89%)	35.23	-0.78 (-2.16%)	18.75 - 44.60	9,706	3,358	1,500